{"id":873,"date":"2022-04-27T00:00:00","date_gmt":"2022-04-27T00:00:00","guid":{"rendered":"https:\/\/www.lunit.io\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/"},"modified":"2022-04-27T00:00:00","modified_gmt":"2022-04-27T00:00:00","slug":"lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark","status":"publish","type":"media-hub","link":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/","title":{"rendered":"Lunit AI solution for PD-L1 expression analysis receives CE mark"},"content":{"rendered":"<ul>\n<li>\n<p>First CE Mark for Lunit AI-powered pathology solution<\/p>\n<\/li>\n<li>\n<p>Lunit to focus on launching \u2018Lunit SCOPE PD-L1\u2019 in Europe within the second half of 2022<\/p>\n<\/li>\n<\/ul>\n<p><\/p>\n<p>Lunit, a leading medical AI provider, today announced it has received the CE-IVDD Mark for \u2018Lunit SCOPE PD-L1 TPS\u2019, an AI-based PD-L1 tumor proportion score (TPS) analyzer. While Lunit\u2019s INSIGHT product scored the CE Mark in 2019 and 2020, this is the first time for a Lunit SCOPE product to receive European approval.<\/p>\n<p>Lunit SCOPE PD-L1 is an AI solution that performs PD-L1 TPS classification that enhances objective and accurate analysis compared to traditional method.<\/p><figcaption>\n<p><img decoding=\"async\" src=\"\/en\/wp-content\/uploads\/EDITOR\/b9de6488-bf87-421a-abc6-633ec4bc47be.png#1269\">Lunit SCOPE PD-L1 \u25b2<\/p>\n<\/figcaption><p>The product, trained with more than 1,000,000 cancer cell images, precisely analyzes PD-L1 biomarker expression and classifies PD-L1 TPS into three groups: 50% or more, 1-49%, and 0%. This digitized assistance substantially supports pathologists in diagnosing the status with high accuracy and consistency in analysis performance.<\/p>\n<p>\u201cThis CE Mark certification is a meaningful milestone,\u201d said Brandon Suh, CEO of Lunit. \u201cIt demonstrates the expansion of Lunit\u2019s offerings to the cancer biopsy field beyond the scope of medical image analysis. As our AI technology gains reliability and recognition, we will do our utmost to pioneer the overseas market.\u201d<\/p>\n<p>Lunit is working on launching Lunit SCOPE PD-L1 in Europe within the second half of 2022, paving the way for deployment and use in European pathology practices.<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"template":"","media-hub-type":[35],"class_list":["post-873","media-hub","type-media-hub","status-publish","hentry","media-hub-type-precision-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lunit AI solution for PD-L1 expression analysis receives CE mark - Lunit<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lunit AI solution for PD-L1 expression analysis receives CE mark - Lunit\" \/>\n<meta property=\"og:description\" content=\"First CE Mark for Lunit AI-powered pathology solution Lunit to focus on launching \u2018Lunit SCOPE PD-L1\u2019 in Europe within the second half of 2022 Lunit, a leading medical AI provider, today announced it has received the CE-IVDD Mark for \u2018Lunit SCOPE PD-L1 TPS\u2019, an AI-based PD-L1 tumor proportion score (TPS) analyzer. While Lunit\u2019s INSIGHT product [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/\" \/>\n<meta property=\"og:site_name\" content=\"Lunit\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@lunit_ai\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/media-hub\\\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\\\/\",\"url\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/media-hub\\\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\\\/\",\"name\":\"Lunit AI solution for PD-L1 expression analysis receives CE mark - Lunit\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/#website\"},\"datePublished\":\"2022-04-27T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/media-hub\\\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.lunit.io\\\/en\\\/media-hub\\\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/media-hub\\\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lunit AI solution for PD-L1 expression analysis receives CE mark\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/#website\",\"url\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/\",\"name\":\"Lunit\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/#organization\",\"name\":\"Lunit\",\"url\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Logo-black.svg\",\"contentUrl\":\"https:\\\/\\\/www.lunit.io\\\/en\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Logo-black.svg\",\"width\":189,\"height\":52,\"caption\":\"Lunit\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lunit.io\\\/ko\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/lunit_ai\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/lunit-inc\",\"https:\\\/\\\/x.com\\\/lunitoncology\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lunit AI solution for PD-L1 expression analysis receives CE mark - Lunit","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/","og_locale":"en_US","og_type":"article","og_title":"Lunit AI solution for PD-L1 expression analysis receives CE mark - Lunit","og_description":"First CE Mark for Lunit AI-powered pathology solution Lunit to focus on launching \u2018Lunit SCOPE PD-L1\u2019 in Europe within the second half of 2022 Lunit, a leading medical AI provider, today announced it has received the CE-IVDD Mark for \u2018Lunit SCOPE PD-L1 TPS\u2019, an AI-based PD-L1 tumor proportion score (TPS) analyzer. While Lunit\u2019s INSIGHT product [&hellip;]","og_url":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/","og_site_name":"Lunit","twitter_card":"summary_large_image","twitter_site":"@lunit_ai","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/","url":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/","name":"Lunit AI solution for PD-L1 expression analysis receives CE mark - Lunit","isPartOf":{"@id":"https:\/\/www.lunit.io\/ko\/#website"},"datePublished":"2022-04-27T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lunit.io\/en\/media-hub\/lunit-ai-solution-for-pd-l1-expression-analysis-receives-ce-mark\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lunit.io\/en\/"},{"@type":"ListItem","position":2,"name":"Lunit AI solution for PD-L1 expression analysis receives CE mark"}]},{"@type":"WebSite","@id":"https:\/\/www.lunit.io\/ko\/#website","url":"https:\/\/www.lunit.io\/ko\/","name":"Lunit","description":"","publisher":{"@id":"https:\/\/www.lunit.io\/ko\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lunit.io\/ko\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.lunit.io\/ko\/#organization","name":"Lunit","url":"https:\/\/www.lunit.io\/ko\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lunit.io\/ko\/#\/schema\/logo\/image\/","url":"https:\/\/www.lunit.io\/en\/wp-content\/uploads\/2025\/10\/Logo-black.svg","contentUrl":"https:\/\/www.lunit.io\/en\/wp-content\/uploads\/2025\/10\/Logo-black.svg","width":189,"height":52,"caption":"Lunit"},"image":{"@id":"https:\/\/www.lunit.io\/ko\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/lunit_ai","https:\/\/www.linkedin.com\/company\/lunit-inc","https:\/\/x.com\/lunitoncology"]}]}},"_links":{"self":[{"href":"https:\/\/www.lunit.io\/en\/wp-json\/wp\/v2\/media-hub\/873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lunit.io\/en\/wp-json\/wp\/v2\/media-hub"}],"about":[{"href":"https:\/\/www.lunit.io\/en\/wp-json\/wp\/v2\/types\/media-hub"}],"author":[{"embeddable":true,"href":"https:\/\/www.lunit.io\/en\/wp-json\/wp\/v2\/users\/3"}],"wp:attachment":[{"href":"https:\/\/www.lunit.io\/en\/wp-json\/wp\/v2\/media?parent=873"}],"wp:term":[{"taxonomy":"media-hub-type","embeddable":true,"href":"https:\/\/www.lunit.io\/en\/wp-json\/wp\/v2\/media-hub-type?post=873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}